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Abstract
The physiological responses to TGF-β stimulation are diverse and vary amongst different cell
types and environmental conditions. Even though the principal molecular components of the
canonical and the noncanonical TGF-β signaling pathways have been largely identified, the
mechanism that underlies the well-established context dependent physiological responses remains
a mystery. Understanding how the components of TGF-β signaling function as a system and how
this system functions in the context of the global cellular regulatory network requires a more
quantitative and systematic approach. Here, we review the recent progress in understanding TGF-β
biology using integration of mathematical modeling and quantitative experimental analysis. These
studies reveal many interesting dynamics of TGF-β signaling and how cells quantitatively decode
variable doses of TGF-β stimulation.
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1. The basics of transforming growth factor-β signaling
TGF-β is the prototypical ligand of the TGF-β superfamily, which signal through receptor
serine/threonine kinases. The superfamily is subdivided into two branches: (1) the TGF-β/
Activin branch and (2) the Bone Morphogenetic Protein (BMP)/Growth and Differentiation
Factor (GDF) branch. Each branch is further divided into subgroups based on sequence
similarity [1]. The TGF-β/Activin branch includes TGF-β, Activin, Inhibin, Nodal, and
Lefty ligands. The BMP/GDF branch includes BMP, GDF, and Mullerian Inhibitory
Substance (MIS) ligands. This review will focus on the quantitative analyses of TGF-β
signaling, which is the most studied ligand in terms of basic signal transduction
mechanisms. There are also substantial quantitative studies of BMP signaling, especially in
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the context of morphogen gradient formation and interpretation, which have been covered in
several excellent reviews [2-5].
TGF-β is expressed in most cell types and is translated into a proprotein that is
proteolytically cleaved into a noncovalently linked mature TGF-β and latency-associated
protein (LAP) [6,7]. The active TGF-β ligand is a 25 kDa dimer, covalently linked by a
disulfide bond between cysteine residues from each monomeric peptide. When bound to
LAP, TGF-β cannot bind to its receptors, resulting in a ligand that lacks bioavailability. Its
bioavailability is further restricted by binding to another protein called Latent TGF-β
Binding Protein (LTBP). The LAP-TGF-β complex is bound by LTBP during the secretion
process [6]. LTBP binds the extracellular matrix and sequesters LAP-TGF-β in vivo [6].
Various proteases cleave LAP and LTBP to liberate the bioactive TGF-β [8]. Bioactive
TGF-β can bind various non-receptor cell surface proteins such as decorin, biglycan, and
betaglycan, which also serve to regulate its bioavailability, most likely through the
enrichment of TGF-β at the plasma membrane [6,7]. Therefore, multiple mechanisms serve
to regulate the bioavailability of TGF-β in vivo.
Once bioavailable TGF-β reaches the surface of the target cell, it binds a homodimer of
TGF-β type II receptors (TβRII) [1]. The TGF-β-TβRII complex provides a structural
interface that facilitates stable complex formation with a homodimer of the TGF-β type I
receptor (TβRI) [8]. Therefore, the active ligand-receptor complex is a heterotetrameric
complex consisting of a dimer of TGF-β and homodimers of both TβRII and TβRI. Within
the active receptor complex, the TβRII, which is a constitutively active kinase, undergoes
autophosphorylation, as well as catalyzes transphosphorylation of the TβRI [8].
Transphosphorylation of the TβRI activates kinase activity. In the TGF-β pathway, Smad2
and Smad3 are receptor-regulated effector proteins (R-Smads), which are phosphorylated by
the activated TβRI at a C-terminal SSXS motif, resulting in R-Smad nuclear accumulation
[8].
TGF-β signaling amplitude and duration can be regulated through the control of receptor
trafficking. The ligand bound activated receptor complex is internalized via endoytosis [9].
Internalization of cell surface receptors can occur through either clathrin-mediated or
caveolae-mediated endocytosis [10]. Through the clathrin pathway, activated ligand-
receptor complexes are brought into early endosomes which are enriched with scaffold
proteins such as SARA and Hrs [9]. The proximity of the activated receptor complex and
scaffold proteins enhances the phosphorylation of Smad2/3 and their affinity towards
Smad4, ultimately activating the nuclear accumulation of Smad4 (also known as the co-
Smad) [11]. Therefore, clathrin-mediated endocytosis may promote TGF-β signaling by
providing a platform for R-Smad phosphorylation and the formation of active Smad
signaling complexes. Ligand-bound receptor complexes in the early endosomes are further
sorted to late endosomes, where TGF-β and the receptors are separated. Some of the
unbound receptors can be recycled to the plasma membrane, while others are degraded,
along with TGF-β, upon fusion with the lysosomes [10]. Since TGF-β is not recycled,
internalization of TGF-β by endocytosis is the primary means of removing active TGF-β
from the cell surface, and lysosomal degradation is the primary means of termination of
TGF-β signaling [12,13].
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Activation of TGF-β receptors initiates both Smad-dependent and Smad-independent
signaling events [14-16]. Since the majority of the quantitative studies of TGF-β signaling
have focused on Smad-dependent events, we will focus our discussion on the dynamics of
the canonical pathway (Smad-dependent). In unstimulated cells, Smads constitutively shuttle
between the cytoplasm and nucleus. Upon ligand stimulation, the Smads accumulate in the
nucleus as the R-Smad/Co-Smad complex formation, which leads to a decrease in their
nuclear export rate [17-19]. The Smad complex binds DNA in conjunction with other
transcription factors and interacts with the general transcription machinery to regulate the
expression of approximately 100-300 target genes [11]. Phosphatase(s) such as PPM1A can
deactivate phospho-R-Smads, resulting in the disassembly of the Smad complex and
providing a means for negative regulation of TGF-β signaling in the nucleus [18]. Therefore,
the intracellular Smad signaling module is a dynamic circuit for ligand sensing.
2. Mathematical modeling of the TGF-β signaling pathway
Conventional cell signaling studies have largely focused on understanding the identity and
the functions of the individual parts of each pathway. It is now realized that cell behaviors
are not only shaped by the identity of the individual system components, but also by the
weighted interactions of components that act together as a system. The systems biology
approach using mathematical models has been proven as a powerful tool in studying such
complex networks [20]. Mathematical modeling is helpful in predicting emergent cell
behaviors and uncovering how the dynamic interactions of signal transducers lead to context
dependent cellular responses [21]. Several mathematical models have been established for
the canonical TGF-β/Smad signaling [13,17,22-29]. These mathematical models provide
quantitative analyses of TGF-β signaling dynamics, leading to a better understanding of the
role of feedbacks in regulating TGF-β signaling responses.
The most common way to describe TGF-β signaling dynamics is through a set of
deterministic ordinary differential equations (ODEs), assuming the signaling molecules are
well-mixed or homogenous in each compartment [20]. The ODEs represent the change of
each signaling molecule over time. In order to perform model simulations and predictions, it
is necessary to know the values for two types of model parameters: the initial conditions of
the pathway that correspond to the concentrations of the signaling molecules at time 0
(before TGF-β stimulation) and the rate constants that characterizes the signaling reactions.
The principal molecular components of TGF-β signaling have been identified, yet relatively
little is known about the quantitative values of particular components' abundance and rate
constants. The lack of experimental data on initial conditions and rate constants is currently
one of the bottlenecks for developing high-quality predictive mathematical models for
signaling networks.
Different approaches have been applied to estimate the model parameters. The initial
conditions of the signaling network can be determined by the absolute abundance of the
signaling proteins and the volume of the signaling compartment. It is possible to estimate the
absolute abundance of a signaling protein when the recombinant protein is available. For
example, the absolute abundance of Smad2 protein per cell can be quantified by
immunoblotting with a standard curve of recombinant tagged-Smad2 protein [30]. Cell
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volume is sometimes roughly estimated from cell diameter or it can be measured more
accurately by confocal microscopy [31]. On the other hand, direct measurement of the rate
constants for different signaling reactions is still experimentally challenging. In order to
estimate the unknown model parameters, optimization algorithms are applied to find the
most feasible parameters that make model simulations fit the experimental datasets as close
as possible [32,33]. During the past few years, some quantitative data has been
experimentally measured for the TGF-β signaling pathway, aiding the modeling efforts for
this network [10,13,19,25]. Figure 1 summarizes our current knowledge about the model
parameters for the canonical TGF-β/Smad signaling network.
3. Quantitative analysis of signaling responses to different TGF-β
stimulations
The cellular responses to TGF-β superfamily ligands depend on the quantity to which the
cells are exposed. In development, TGF-β superfamily members form morphogen gradients
to determine the fates of cells [2]. Cells read the TGF-β concentration with high precision, as
they can distinguish subtle differences in the concentration gradients and orchestrate
different cell fates [34]. One of the best examples is the responses of embryonic Xenopus
cells to activin, in which five distinct cell responses or fates are observed by varying activin
doses [34]. However, the mechanism by which cells are able to accurately decode the
concentration of bioavailable TGF-β and elicit a corresponding cellular response remains
largely unknown.
3.1 The Smad signaling response correlates with TGF-β molecules per cell rather than the
concentration of TGF-β
An early study with mathematical models has shown that cell density affects signaling
dynamics in response to the same concentration of ligand [35]. Through modeling analyses
of receptor trafficking networks, Zi et al. showed that with the same concentration of ligand
stimulation, cells have distinct signaling durations that depend upon cell density, where
signaling persists longer when cell density is decreased [35]. Additionally, the model
analyses indicate that the dose–response curve of signaling is shifted to the right as the cell
density is increased, suggesting that increasing cell density allows for insensitivity to lower
doses of ligand. Thus, the key parameter for successful experimental design cannot be
“concentration of ligand”, but rather must be “molecules of ligand per cell”, which takes
into account the number of cells in the experiment. Further model simulations indicate that
signaling responses are regulated by the ratio of ligand to cell surface receptor number [35].
In cell culture experiments, individual cells are likely to express different amounts of
receptors at cell surface. Thus, when all cells are exposed to the same amount of ligand, the
ratio of ligand to cell surface receptor number in each cell will be different, which might
cause heterogeneous signaling responses at single cell level.
To provide additional evidence that cellular responses to ligand occur in terms of “molecules
per cell” rather than by the concentration of the ligand, Clarke et al. investigated how cells
transduce TGF-β doses into variable kinetic profiles of Smad2 phosphorylation at C-
terminal SSXS motif (P-Smad2) by quantitative experimental assays [12]. Clarke et al.
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measured P-Smad2 levels in a two-level factorial experiment by varying four experimental
parameters (TGF-β concentration, cell number at seeding, plate type, and medium volume).
When the P-Smad2 data is plotted versus TGF-β concentration, large variations are observed
for the same TGF-β concentration among different experimental setups. In contrast, the
variation of P-Smad2 levels is significantly reduced if these levels are plotted versus the
number of TGF-β molecules per cell. This result implies that the ligand dose expressed as
TGF-β molecules per cell is a better predictor of P-Smad2 levels, which is in agreement with
early modeling studies about the impact of cell density on signaling response.
Ligand depletion in the TGF-β network provides additional complexity and increases the
difficulty of predicting the time dependent signaling responses. For example, the number of
TGF-β molecules per cell in the media changes substantially with time because the cells
deplete TGF-β from the surrounding medium. It was shown that TβRII defective, but not
TβRI defective, cell lines lost their ability to deplete TGF-β from the medium [12]. Thus,
TβRII helps to shape the Smad signal amplitude and duration by constitutively depleting
extracellular TGF-β. TGF-β depletion most likely occurs through TβRII-mediated
endocytosis. However, direct evidence that supports this notion remains to be presented in
the literature. In this aspect, TGF-β degradation shares many similarities to EGF or TGF-α
[36,37] in that ligand-induced endocytosis does not merely serve as a mechanism for “down-
regulation” of signaling, but also provides a mechanism whereby the receptor can
continuously track the changes in the secretion of TGF-β by nearby cells. It should be noted
that most studies of TGF-β signaling assume that TGF-β concentration in the medium is
sufficient to describe the input variable (potency of ligand). Consequently, most modeling
studies have assumed a constant level of TGF-β during signaling over time. However, in cell
based experiments TGF-β concentration in the medium changes substantially with time,
especially for low doses of TGF-β. Therefore, the assumption that TGF-β concentration is
constant in medium might be appropriate for high doses of TGF-β, but it is invalid for low
doses of TGF-β.
3.2 TGF-β dose-responses are time dependent
Earlier experimental and modeling analyses showed that Smad signal amplitude is gradually
increased with the increments of TGF-β doses [23,24,38]. This leads to an important
question about how cells convert continuous TGF-β doses into discrete or binary cellular
fate decisions. Since most of modeling studies in the TGF-β field do not account for the
TGF-β input variable by assuming constant TGF-β concentration in medium, this omission
often results in unreliable predictions of Smad signaling kinetics in response to variable
doses of TGF-β stimulation [13]. Recently, we developed an improved mathematical model
to describe the dynamics of Smad signaling in response to TGF-β [13]. The model was
composed of TGF-β receptor trafficking, Smad phosphorylation and Smad
nucleocytoplasmic shuttling. More importantly, it took into account the dynamics of TGF-β
depletion. Model parameters were estimated by fitting to several time course datasets, which
include variables of TGF-β depletion in the medium, Smad2 nuclear localization and P-
Smad2 dynamics. The model was further tested for its ability to predict the P-Smad2
signaling upon pulsation of TGF-β stimulations. With this data-calibrated model, novel
predictions were made through model simulations. It was shown that TGF-β signaling
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responses display different sensitivities to ligand doses at different time scales [13]. In this
study, modeling simulations and experimental results show that while short-term P-Smad2 is
graded, long-term P-Smad2 response is switch-like to changes in TGF-β doses (Figure 2). In
the short-term graded response, P-Smad2 signal gradually increases with the increment of
TGF-β dose. In the long-term switch-like response, a small change of TGF-β dose within a
certain range results in a large change in P-Smad2 response. Furthermore, a switch-like
response is observed for TGF-β induced long-term gene expression and growth inhibitory
responses. Additional model perturbation experiments predicted that the long-term
switchlike P-Smad2 response is mainly affected by the parameters related to the ligand
depletion. This prediction was experimentally confirmed [13].
3.3 The TGF-β pathway is insensitive to high frequency noise
While extensive studies have focused on signaling responses to continuous TGF-β
stimulations, little is known about how cells respond to short pulses of TGF-β stimulations.
Taking advantage of model simulations, Zi et al. have shown that short-term TGF-β pulse
stimulation results in transient P-Smad2, whereas serial pulses result in sustained P-Smad2,
similar to that seen with continuous stimulation [13]. To generate a sustained response, the
gap between repeated pulse stimulation is ∼30 min. This result suggests that with a strong
TGF-β stimulation, the pre-bound receptors are capable of sustaining the signaling response
for half of an hour and tiding it to the next stimulus. Incidentally, this optimal gap period is
approximately the time to reach maximum Smad2 phosphorylation and nuclear
accumulation of Smad2 after TGF-β stimulation [13]. Therefore, there is a time-delay in the
TGF-β signaling system, which may be attributed to ligand-bound receptor endocytosis or
Smad nucleocytoplasmic shuttling dynamics. Because of this built-in time-delay, the TGF-β
signaling system can filter high frequency changes (short time pulsations) in ligand
stimulations. Thus, combining mathematical modeling with guided experiments enables new
discoveries in systems properties of TGF-β signaling that would have been difficult to reveal
using the traditional biochemical approaches alone. The functional significance of pulses of
TGF-β has yet to be shown in vivo, but is theoretically occurring within tissues, where the
extracellular volume and local secretion of TGF-β is extremely small in magnitude, resulting
in a largely noisy extracellular level of TGF-β. Such noise would then be dampened by the
delayed TGF-β response that has been observed in cell culture models.
4. Quantitative analysis of transient and sustained signaling responses
The duration of signaling responses can be critical for alerting cell fate decisions in response
to growth factor. Previous work with PC12 cells showed that epidermal growth factor (EGF)
induces transient activation of extracellular signal-regulated kinase (ERK) and results in cell
proliferation, while sustained ERK activation triggered by nerve growth factor (NGF) leads
to cell differentiation [39,40]. Although some of these effects could be due to non-ERK
dependent responses to the different ligands, these experiments propose an interesting
notion, where the duration of ligand stimulation can determine the prevailing cellular
response.
In the case of the TGF-β signaling network, the duration of Smad signaling response seems
to be context dependent. Experimental studies have shown that keratinocyte epithelial cells
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have sustained phospho-Smad responses to TGF-β, while some fibroblast and tumor cells
display transient Smad activation [41,42]. It was hypothesized that sustained TGF-β
signaling may be required for growth inhibition, while transient signaling may cause the
resistance to anti-proliferative effects of TGF-β in certain tumor cells [41]. However, the
exact mechanism underlying the variation of Smad signal duration in different cell types
remains to be elucidated. Here we summarize the time dependent changes in the cellular
responses to TGF-β.
4.1 Sequestration of TGF-β receptors by endocytosis
TGF-β signaling is initiated by the binding of TGF-β to TβRI and TβRII. The activation of
the ligand-receptor complex is a relatively fast step in the TGF-β signal transduction
pathway. An early study from Wrana et al. shows that the phosphorylation of TβRI in the
receptor complex peaks at about 2 minutes after TGF-β stimulation [43]. The signal is
relayed to the activation of Smad proteins, which arrive at their maximal levels in about
30-60 minutes. The time delay between ligand receptor complex and R-Smad activation may
due to intermediate processes, including receptor endocytosis, the recruitment of Smads to
receptor complex and Smad activation. After 30-60 minutes, the phosphorylation of Smads
correlates with the degree of TGF-β-receptor complex level, which might be due continuous
nucleocytoplasmic shuttling of the Smads, but this shuttling fails to explain why there is a
prominent delay following receptor activation and prior to Smad phosphorylation [25,44].
Although it has been shown that two main types of endocytosis mediate the internalization
of TGF-β receptors, clathrin-dependent and clathrin-independent [9,45], different lines of
experimental evidence display discrepancies in the requirement of receptor internalization
for Smad phosphorylation. Using potassium depletion, which interferes with clathrin-
dependent internalization of receptors, P-Smad2 levels are reduced in Mv1Lu cells [10,46].
On the other hand, potassium depletion or mutant dynamin (K44A) in L17-TβRI cells
reveals that receptor trafficking is entirely dispensable for TGF-β signaling to occur [9,47].
Even though there is little debate about whether the TGF-β receptors undergo endocytosis,
the precise role of receptor endocytosis in signaling remains controversial [9]. Several lines
of evidence support a positive role of endocytosis on R-Smad phosphorylation
[10,46,48,49], while there are several reports describing Smad activation immediately at the
cell surface without need of receptor endocytosis [47,50,51]. The disagreement among these
studies could be attributed to different cell types and experimental systems. Despite the
variable effects of receptor endocytosis on Smad phosphorylation, activation of non-Smad
signaling pathways by TGF-β appears to require receptor internalization [51,52].
To understand the role of receptor endocytosis on TGF-β signaling, mathematical models
were established by focusing on TGF-β receptor endocytosis. Vilar et al. developed a
concise model for TGF-β receptor trafficking and the ligand-receptor interactions. This
model predicts that the duration of signaling activity is determined by the ratio of the
constitutive to the ligand-induced degradation rate of the receptors, termed the “constitutive-
to-induced degradation ratio” (CIR). Model analyses suggest that signal activity is transient
with a low CIR, while sustained signal response is observed with a high CIR. The model has
some assumptions including: (1) TGF-β signaling activity is proportional to the level of
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ligand-receptor complexes in the internalized endosomes, and (2) Ligand-receptor
complexes between type I and type II receptors have the same constitutive degradation rate.
In addition, the model lumps the processes including non-clathrin dependent internalization,
recycling and the degradation of the receptors into one reaction as “the ligand-induced
receptor degradation from plasma membrane”. Thus, CIR defined in Vilar's model is not
directly determined by the ratio of the reaction rate constants for constitutive and ligand-
induced degradations. Instead, it refers to the balance of the overall effect of the combined
processes of the two branches of receptor degradation machinery.
Subsequently, a mathematical model developed by Zi and Klipp includes two major types of
TGF-β receptor endocytosis, Smad activation and Smad nuclearcytolasmic shuttling [29].
Similar as Vilar's model, the extended model assumes that Smad activation is proportional to
the ligand-receptor complex in early endosomes. The model simulations using different sets
of parameter values suggest that Smad activation is regulated by the balance between
clathrin dependent endocytosis (kiEE) and caveolar/lipid-raft mediated (clathrin-
independent) endocytosis (kiCave). If clathrin-dependent internalization is dominant (kiEE ≫
kiCave), Smad activation becomes a sustained response. On the other hand, if clathrin-
independent endocytosis is overwhelming (kiCave ≫ kiEE), Smad activation displays a
transient response. Interestingly, the simulation results suggest that changing the balance
between the two branches of endocytosis has relatively little effect on the early Smad signal,
and has larger effect in reshaping long term Smad activity. This hypothesis might explain
the variations among experimental observations about the impact of inhibiting TGF-β
receptor endocytosis on TGF-β signaling responses, where the different model systems may
have different ratio of clathrin-dependent to clathrin-independent endocytosis. Thus, in a cell
line with similar rates of clathrin-dependent and clathrin-independent endocysis, an
inhibition of clathrin-dependent will make clathrin-independent endocysis (ligand-induced
receptor degradation) dominant and result in a reduction in Smad activity. In other cell
types, if the clathrin-dependent endocytosis is overwhelmed by clathrin-independent
endocytosis, inhibiting clathrin-dependent internalization will not shift the balance between
these two endocytosis branches and should result in little effect on the perturbation of
signaling responses. Moreover, the inhibitors of endocytosis used in previous experimental
studies may not be very specific and could have some off target effects. In the future, a
systems biology approach can be useful to clarify this issue by combining mathematical
models with quantitative experimental data of receptors and Smad kinetics.
4.2 Quantitative analysis of the dynamics of Smad nuclear import and export
A prominent feature of TGF-β signaling is the continuous shuttling of Smads in and out the
nucleus, in both treated and untreated cells [44,53]. Ligand-induced nuclear accumulation of
R-Smad and Co-Smad is relatively slow and peaks at ∼45 min after TGF-β exposure.
Ligand-induced Smad shuttling dynamics is considered to be a prevailing mechanism for
Smads to continuously monitor receptor activity [44,53]. Different mechanisms have been
invoked to account for Smad nucleocytoplasmic shuttling dynamics. Mathematical modeling
analysis has been instrumental in differentiating various hypotheses [18]. Clarke et al. [17]
was the first to publish a kinetic model of Smad signaling dynamics. The simple kinetic
model includes R-Smad phosphorylation/dephosphorylaton, heterodimerization with Smad4,
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and nucleocytoplasmic shuttling steps. Analyzing the existing data with this model led to
several novel hypotheses for Smad nuclear accumulation during TGF-β signaling. Through
parameter sensitivity analysis, Clarke et al. posited that (1) the balance between the rates of
R-Smad phosphorylation in the cytoplasm and phospho-R-Smad dephosphorylation in the
nucleus determines Smad nuclear accumulation. (2) Smad homo- or hetero-oligomerization
could protect the phospho-R-Smads from rapid dephosphorylation and therefore promote
Smad nuclear accumulation. (3) Nuclear retention factors alone are insufficient for induction
of Smad nuclear accumulation. Schmierer et al. investigated the relationship between
receptor activation and Smad shuttling dynamics using a combined mathematical modeling
and systematic experiment approach [25]. Two competing models were developed based on
different assumptions of the Smad import mechanism. The retention/enhanced complex
import (RECI) model assumes Smad complexes to be imported at a faster rate than the
monomeric species, while the retention only (RO) model sets identical import rates for both
Smad complexes and monomeric species but only allows nuclear retention of complexes.
The two competing models were simultaneously fit to four sets of kinetic empirical data.
The result of comparative analysis shows that RECl is clearly a more accurate model.
Moreover, the RECl model also shows excellent agreement with fluorescence recovery after
photobleaching (FRAP) data of GFP-Smad2 that were not used to construct the model. The
FRAP experiment was used to infer the shuttling of GFP-Smad2 between nucleus and
cytoplasmic compartments. Therefore, quantitative analysis of Smad shuttling led to the
notion that the Smad complex must have a faster nuclear import rate and that the
phosphatase(s) that deactivate R-Smads likely resides in the nucleus. A novel insight that
comes out of the modeling analysis is that time-delayed coupling between receptor activity
and Smad nuclear accumulation could function as a low-pass filter to dampen the noise in
receptor activity [25,54].
4.3 Negative feedbacks in TGF-β signaling
Negative feedback in a signal transduction cascade is one of the major mechanisms for
desensitization of sustained ligand stimulation and generation of transient, sometimes
oscillating signaling outputs [55]. Even though transient or oscillatory responses associated
with sustained TGF-β exposure are not ubiquitous, potential negative feedback motifs have
been identified. The most well characterized example is Smad7, a TGF-β-inducible early
response gene [56,57]. Smad7 antagonizes TGF-β signaling through multiple mechanisms,
both in the cytosol and the nucleus. Since Smad7 can bind the TGF-β receptors, but lacks the
SXSS motif commonly found in R-Smads, it has been proposed that Smad7 is likely to be a
pseudo substrate and a competitive inhibitor of R-Smads [56,57]. Owing to its ability to
form stable complexes with the TGF-β receptors, PP1 phosphatase [58], or the
ubiquitination E3 ligase Smurf1 and Smurf2 [59], Smad7 serves as an adapter to mediate
inactivation of TGF-β receptors through dephosphorylation or ubiquitin-proteasomal
degradation. Besides targeting receptors for inactivation, Smad7 also appears to be involved
in repressing TGF-β-dependent transcription through either the disruption of R-Smad/Co-
Smad/DNA complexes or the recruitment of histone deacetylases [60]. Regardless of the
exact biochemical mechanisms of Smad7, the induction of Smad7 by TGF-β and its function
as an antagonist for TGF-β signaling are very compelling. A key question is, “what is the
strength of this feedback and to what degree does it impact TGF-β signal transduction.”
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Melke at al. analyzed a more comprehensive model of TGF-β/Smad signaling in endothelial
cells that included canonical Smad signaling. They found that negative feedback through
Smad7 was important for terminating signaling and for conferring global robustness to the
TGF-β pathway [24].
TMEPAI is another antagonist of TGF-β signaling and is transcriptionally induced by ligand
exposure [61]. TMEPAI possesses both transmembrane and Smad interacting domain
(SIM). The inhibition of TGF-β signaling can be attributed to sequestration of both
unphosphorylation and phosphorylated R-Smads from interacting with the receptors or
Smad4 [61]. While inhibition of TGF-β signaling by Smad7 and TMEPAI predominantly
occurs in the early step of signaling propagation, the negative feedback loop that involves
SnoN appears to target the downstream signaling cascade at the chromatin level. SnoN and
its relative Ski are both transcriptional co-repressors of the Smad signaling complex [62,63].
In the early phase of TGF-β stimulation, SnoN is destabilized by association with activated
R-Smads and ubiquitin E3 ligases such as Arkadia [64-67]. Degradation of SnoN/Ski
unleashes the full activity of the Smad complex, resulting in the transcriptional activation of
target genes. SnoN is one of the TGF-β inducible genes and the elevated SnoN restrains the
activity of Smad complexes [64]. Therefore, there are at least three negative feedback loops
associated with TGF-β signaling. All of these are initiated by transcriptional induction of the
antagonist, although spatial and temporal variations exist among them.
4.4 Are there oscillations in TGF-β signaling responses?
Oscillations of signaling responses have been observed in some pathways with negative
feedbacks, for example, NF-κB, p53 and Erk systems [37,68,69]. Modeling analyses have
shown that biochemical oscillations can occur if four general requirements are satisfied:
negative feedback, time delay, nonlinearity of the reaction kinetics, and tightly controlled
timescales of opposing chemical reactions [70]. Since different negative feedbacks have
been proposed for regulating TGF-β signaling [71], theoretically, it is possible to generate
oscillating responses in the TGF-β network. Recent modeling analyses by extensive
sampling of parameter space show that oscillating Smad signaling can appear by fine-tuning
only a few parameters related to negative feedback (e.g. Smad7) [22,28]. However, it is still
an open question about whether there are oscillations in TGF-β network because no
oscillations of TGF-β signaling have yet been observed in cells. One reason could be that the
negative feedback regulations of TGF-β network may not be strong enough at the
endogenous level. Moreover, the time-delay between negative feedback and Smad activation
might not be coupled in a proper time scale at in vivo conditions. Last but not least, cell
signaling often results in heterogeneous responses within single cells. Averaging signaling
dynamics at cell population levels can mask dynamic signaling mechanisms within
individual cells [72]. Oscillation responses may appear upon investigation at the single cell
level in a variety of cell lines and culture conditions.
4.5 Modeling cell context specific TGF-β signaling
It has been long recognized that the cellular responses triggered by TGF-β are often cell type
specific and stimulation specific [73]. For example, TGF-β is a potent inhibitor of normal
epithelial cell proliferation but acts to stimulate fibroblast growth [73]. Even in the same cell
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type, TGF-β can produce opposite proliferation effects depending on the presence of other
growth factors. In the presence of PDGF, TGF-β stimulates growth of Myc-1 cells, and in
the presence of EGF, TGF-β inhibits growth of the exact same cells [73]. The exact
molecular mechanisms underlying these contradictory cellular responses remain largely
elusive. One possible explanation to account for these observations is that the pathways
activated by TGF-β vary among different cell types and are restrained by crosstalk with
other signaling pathways. Even though TGF-β signals through Smad2 and Smad3 in most
cell types through ALK-5, in endothelial and hepatic stellate cells TGF-β induces
phosphorylation of both Smad1/5 and Smad2 via ALK-1 and ALK-5, respectively
[24,38,74]. Based on this evidence, Melke et al. developed a mathematical model for the
TGF-β pathway in endothelial cells, taking parallel activation of ALK1 and ALK5 into
consideration. Their model recapitulates the kinetics of the experimental data and correctly
predicts the behavior in experiments where the system is perturbed [24]. This study
highlights a need to develop mathematical modeling tailored to a specific biological context
in order to understand the multifunctional nature of TGF-β signaling.
5. Outlook and concluding remarks
TGF-β signaling is spatiotemporally regulated in at least three compartments (extracellular,
cytosol and nucleus). Quantitative analysis of the TGF-β signaling pathway is still very
much in its infancy. At present, modeling efforts have been focused on the canonical TGF-β
signaling cascade. As TGF-β signals through both canonical and noncanonical pathways, it
is imperative to develop mathematical models that comprise both pathways in order to
accurately predict overall TGF-β signaling. Since the noncanonical pathway is often cell
type dependent and operates in the context of other signaling networks, it will be a major
challenge to develop such models. Another challenge is to understand the quantitative
coupling between Smad signaling kinetics and gene expression profiles. Most of the
mathematical models developed so far assume that the dynamics of Smad2 and Smad3
phosphorylation is similar and indistinguishable. However, the biological functions of
Smad2 and Smad3 are clearly different, based on mouse knockout studies and DNA
microarray analysis [75,76]. The abundance of Smad2 and Smad3 varies significantly in
different cell types and the ratio of Smad2 and Smad3 influences the resulting cellular
responses to TGF-β stimulation [17,77]. Future modeling efforts need to consider how to
model the R-Smads separately. Finally, given the emerging role of TGF-β type III receptor
in modulating TGF-β signaling [78], it would be interesting to quantitatively assess their
contributions to the signaling dynamics. As more quantitative TGF-β signaling data becomes
readily accessible, we anticipate that the innovative systems biology approach to study TGF-
β/Smad signaling will fundamentally advance our knowledge in this major signaling
network.
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TβRI TGF-β type I receptors
TβRII TGF-β type II receptors
BMP Bone Morphogenetic Protein
GDF Growth and Differentiation Factor
ODEs Ordinary Differential Equations
P-Smad2 Smad2 phosphorylation at C-terminal SSXS motif
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Scheme of the compartmentalized TGF-β model. The kinetic parameter information is
approximately estimated according to the experimental data from different cell types. The
nuclear export rate constants of Smads are scaled with the ratio of cytoplasmic to nuclear
volume size. It is necessary to calibrate these parameter values with quantitative data sets for
modeling of TGF-β signaling responses in a specific cell type.
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Model simulations for the time-course profile of P-Smad2 dose-response in HaCaT cells.
Cells have distinct interpretations to TGF-β doses at different time scales. The early P-
Smad2 signal (e.g. before 2 hour) displays a graded response to different doses of TGF-β,
while the late P-Smad2 response (e.g. at 24 hour) is switch-like. The long-term ultrasensitive
signaling response is critical for cellular fate decisions, for example, cell growth arrest.
Zi et al. Page 17
FEBS Lett. Author manuscript; available in PMC 2014 August 10.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
